-Search query
-Search result
Showing 1 - 50 of 51 items for (author: abernathy & me)
EMDB-27177:
sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein
Method: single particle / : Abernathy ME, Barnes CO
PDB-8d48:
sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein
Method: single particle / : Abernathy ME, Barnes CO
EMDB-27939:
Structure of the human ACE2 receptor in complex with antibody Fab fragment, 05B04
Method: single particle / : Barnes CO
EMDB-24853:
Modified BG505 SOSIP-based immunogen RC1 in complex with elicited mAb Ab283MUR Fab and 8ANC195 Fab
Method: single particle / : Abernathy ME, Bjorkman PJ
EMDB-24854:
Modified BG505 SOSIP-based immunogen RC1 in complex with elicited mAb Ab1170NHP Fab and 8ANC195 Fab
Method: single particle / : Abernathy ME, Bjorkman PJ
EMDB-24855:
Modified BG505 SOSIP-based immunogen RC1 in complex with Rabbit 2249 post-Prime polyclonal Fabs
Method: single particle / : Barnes CO, DeLaitsch AT, Bjorkman PJ
EMDB-24856:
Modified BG505 SOSIP-based immunogen RC1 in complex with Rabbit 2249 post-Boost 1 polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24857:
Modified BG505 SOSIP-based immunogen RC1 in complex with Rabbit 2249 post-Boost 2 polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24858:
Modified BG505 SOSIP-based immunogen RC1 in complex with Rabbit 2249 post-Boost 3 polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24859:
Modified BG505 SOSIP-based immunogen RC1 in complex with Rabbit 2249 post-Boost 4 polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24860:
Modified BG505 SOSIP-based immunogen RC1 in complex with NHP 1 post-Prime polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24861:
Modified BG505 SOSIP-based immunogen RC1 in complex with NHP 1 post-Boost 1 polyclonal Fabs
Method: single particle / : DeLaitsch AT, Barnes CO, Bjorkman PJ
EMDB-24072:
Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab
Method: single particle / : Abernathy ME, Bjorkman PJ
PDB-7mxe:
Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab
Method: single particle / : Abernathy ME, Bjorkman PJ
EMDB-23393:
Structure of the SARS-CoV-2 spike trimer in complex with mRNA vaccine induced neutralizing antibody C601
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-23394:
Structure of the SARS-CoV-2 spike trimer in complex with mRNA vaccine induced neutralizing antibody C603
Method: single particle / : Yang Z, Barnes CO, Bjorkman PJ
EMDB-23395:
Structure of the SARS-CoV-2 spike trimer in complex with mRNA vaccine induced neutralizing antibody C643
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-23396:
Structure of the SARS-CoV-2 spike trimer in complex with mRNA vaccine induced neutralizing antibody C663
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-23397:
Structure of the SARS-CoV-2 spike trimer in complex with mRNA vaccine induced neutralizing antibody C666
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-23398:
Structure of the SARS-CoV-2 spike trimer in complex with mRNA vaccine induced neutralizing antibody C669
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-23399:
Structure of the SARS-CoV-2 spike trimer in complex with mRNA vaccine induced neutralizing antibody C670
Method: single particle / : Yang Z, Barnes CO, Bjorkman PJ
EMDB-22729:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
Method: single particle / : Barnes CO, Malyutin AG, Bjorkman PJ
EMDB-22730:
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
Method: single particle / : Malyutin AG, Barnes CO, Bjorkman PJ
EMDB-22731:
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
Method: single particle / : Barnes CO, Malyutin AG, Bjorkman PJ
EMDB-22732:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
Method: single particle / : Dam KA, Barnes CO, Bjorkman PJ
EMDB-22733:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
Method: single particle / : Sharaf NG, Barnes CO, Bjorkman PJ
EMDB-22734:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
Method: single particle / : Abernathy ME, Barnes CO, Bjorkman PJ
EMDB-22735:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
Method: single particle / : Abernathy ME, Barnes CO, Bjorkman PJ
EMDB-22736:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
Method: single particle / : Barnes CO, Bjorkman PJ
EMDB-22737:
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144
Method: single particle / : Barnes CO, Esswein SR, Bjorkman PJ
PDB-7k8s:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
Method: single particle / : Barnes CO, Malyutin AG, Bjorkman PJ
PDB-7k8t:
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
Method: single particle / : Malyutin AG, Barnes CO, Bjorkman PJ
PDB-7k8u:
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
Method: single particle / : Barnes CO, Malyutin AG, Bjorkman PJ
PDB-7k8v:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
Method: single particle / : Dam KA, Barnes CO, Bjorkman PJ
PDB-7k8w:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
Method: single particle / : Sharaf NG, Barnes CO, Bjorkman PJ
PDB-7k8x:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
Method: single particle / : Abernathy ME, Barnes CO, Bjorkman PJ
PDB-7k8y:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
Method: single particle / : Abernathy ME, Barnes CO, Bjorkman PJ
PDB-7k8z:
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
Method: single particle / : Barnes CO, Bjorkman PJ
PDB-7k90:
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144
Method: single particle / : Barnes CO, Esswein SR, Bjorkman PJ
EMDB-20739:
HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074
Method: single particle / : Abernathy ME, Barnes CO, Gristick HB, Bjorkman PJ
EMDB-20740:
HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074
Method: single particle / : Abernathy ME, Barnes CO, Gristick HB, Bjorkman PJ
PDB-6udj:
HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074
Method: single particle / : Abernathy ME, Barnes CO, Gristick HB, Bjorkman PJ
PDB-6udk:
HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074
Method: single particle / : Abernathy ME, Barnes CO, Gristick HB, Bjorkman PJ
EMDB-20175:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
EMDB-20176:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab874NHP
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
EMDB-20177:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab897NHP
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
EMDB-20178:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab275MUR
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
PDB-6orn:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
PDB-6oro:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab874NHP
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
PDB-6orp:
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab897NHP
Method: single particle / : Abernathy ME, Gristick HB, Bjorkman PJ
Pages: